People · Operator
Named in public records as an officer, director or promoter · active 2008–2020 · Other, Other Health Care, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pulmonx Corp | — | Other | Series C | $143.8M | $1.1B | 2008 |
| Revascular Therapeutics Inc | — | Other | Series A | $25.8M | $109.5M | 2008 |
| ProMed Inc | — | Other Health Care | Series A | $21.9M | $30.3M | 2009 |
| Biotricity Inc. | — | Biotechnology | Series A | $10.6M | $6.0M | 2020 |
| Ovalis Inc | — | Other Health Care | Seed | $3.1M | $12.2M | 2009 |
| Fliqz Inc | — | Other Technology | Seed | $1.0M | $34.1M | 2009 |
Steve Salmon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve Salmon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Fitzgerald | 4 | 6 |
| Richard Ferrari | 3 | 15 |
| David Mauney | 2 | 10 |
| Richard Ginn | 2 | 3 |
| Ronald Jabba | 2 | 2 |
| David White | 1 | 11 |
| Annette Campbell-White | 1 | 11 |
| Michael Baker | 1 | 8 |
| Dana Mead | 1 | 7 |
| Dana G. Mead, Jr. | 1 | 7 |
| David Rosa | 1 | 5 |
| David A. Rosa | 1 | 5 |
| Howard Palefsky | 1 | 4 |
| Carl Simpson | 1 | 4 |
| Patricia Kennedy | 1 | 3 |
| Norman Betts | 1 | 3 |
| A. Barr Dolan | 1 | 3 |
| Michael Lynn | 1 | 3 |
| MARTIN SCHNEIDER | 1 | 2 |
| Ronald A. McClurg | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.